(MedPage Today) — For patients with moderate to severe acute respiratory distress syndrome (ARDS), prolonged sedation with the inhaled volatile agent sevoflurane resulted in worse outcomes than intravenous propofol, the randomized SESAR trial…
Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/114727
Author :
Publish date : 2025-03-19 14:31:00
Copyright for syndicated content belongs to the linked Source.
